These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 22209677)
1. Metabolic memory: mechanisms and implications for diabetic retinopathy. Zhang L; Chen B; Tang L Diabetes Res Clin Pract; 2012 Jun; 96(3):286-93. PubMed ID: 22209677 [TBL] [Abstract][Full Text] [Related]
2. Metabolic memory for vascular disease in diabetes. Aschner PJ; Ruiz AJ Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S68-74. PubMed ID: 22650227 [TBL] [Abstract][Full Text] [Related]
3. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846 [TBL] [Abstract][Full Text] [Related]
4. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways. Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677 [TBL] [Abstract][Full Text] [Related]
5. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view. Chilelli NC; Burlina S; Lapolla A Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818 [TBL] [Abstract][Full Text] [Related]
6. Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. Sartore G; Chilelli NC; Burlina S; Lapolla A Acta Diabetol; 2013 Jun; 50(3):437-42. PubMed ID: 23417155 [TBL] [Abstract][Full Text] [Related]
7. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Klein R; Klein BE; Moss SE Ann Intern Med; 1996 Jan; 124(1 Pt 2):90-6. PubMed ID: 8554220 [TBL] [Abstract][Full Text] [Related]
8. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Lopes-Virella MF; Baker NL; Hunt KJ; Lyons TJ; Jenkins AJ; Virella G; Diabetes Care; 2012 Jun; 35(6):1333-40. PubMed ID: 22511260 [TBL] [Abstract][Full Text] [Related]
9. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM; Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432 [TBL] [Abstract][Full Text] [Related]
10. The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications. Testa R; Bonfigli AR; Prattichizzo F; La Sala L; De Nigris V; Ceriello A Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452927 [TBL] [Abstract][Full Text] [Related]
11. Does tight control of systemic factors help in the management of diabetic retinopathy? Rajalakshmi R; Prathiba V; Mohan V Indian J Ophthalmol; 2016 Jan; 64(1):62-8. PubMed ID: 26953026 [TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy. Yamagishi S; Matsui T Curr Pharm Biotechnol; 2011 Mar; 12(3):362-8. PubMed ID: 20939798 [TBL] [Abstract][Full Text] [Related]
13. The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. Jeon WS; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY Diabetes Res Clin Pract; 2016 Jun; 116():46-53. PubMed ID: 27321316 [TBL] [Abstract][Full Text] [Related]
14. A correlation between oxidative stress and diabetic retinopathy: An updated review. Hussain A; Ashique S; Afzal O; Altamimi MA; Malik A; Kumar S; Garg A; Sharma N; Farid A; Khan T; Altamimi ASA Exp Eye Res; 2023 Nov; 236():109650. PubMed ID: 37734426 [TBL] [Abstract][Full Text] [Related]
15. Worsening of diabetic retinopathy after improvement of glycemic control. Davis MD Arch Ophthalmol; 1998 Jul; 116(7):931-2. PubMed ID: 9682709 [No Abstract] [Full Text] [Related]
16. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. Wan TT; Li XF; Sun YM; Li YB; Su Y Biomed Pharmacother; 2015 Aug; 74():145-7. PubMed ID: 26349976 [TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications. Chiarelli F; de Martino M; Mezzetti A; Catino M; Morgese G; Cuccurullo F; Verrotti A J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925 [TBL] [Abstract][Full Text] [Related]
18. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms. Tonna S; El-Osta A; Cooper ME; Tikellis C Nat Rev Nephrol; 2010 Jun; 6(6):332-41. PubMed ID: 20421885 [TBL] [Abstract][Full Text] [Related]
19. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. Kumaramanickavel G; Ramprasad VL; Sripriya S; Upadyay NK; Paul PG; Sharma T J Diabetes Complications; 2002; 16(6):391-4. PubMed ID: 12477623 [TBL] [Abstract][Full Text] [Related]
20. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes. Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]